close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Drugs for Treating Systemic Lupus Erythematosus: Global Markets

  • Published: March 2014
  • |
  • Report Code: PHM159A

REPORT HIGHLIGHTS

The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.

This report provides:

  • An overview of the global market for drugs and therapeutics used to treat systemic lupus erythematosus (SLE) 
  • Analyses of global market trends, with data from 2013 and projections of CAGRs through 2018.
  • Analyses of factors influencing market demand such as the industry's structure, governmental regulations, and developing technologies
  • Details concerning the developmental product pipeline for therapeutics uesd to treat SLE
  • Profiles of leading companies in the industry.

SAMPLE FIGURE
GLOBAL SALES OF DRUGS TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, THROUGH 2018
($ MILLIONS)
GLOBAL SALES OF DRUGS TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, THROUGH 2018
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE OF REPORT

The scope of this report focuses on the pharmaceutical segment. We have compiled a study of the market, as well as current and emerging modes of treatment. We present the market segment’s economic environment, market factors and potential, and forecasts for 2013 to 2018. This study will be of interest to the drug industry, patients and the medical community. It will also be of interest to suppliers of products and services to this market area.

ANALYST’S CREDENTIALS

Dr. Sanjukta Bhattacharyya is the BCC Research analyst of this report. She holds a PhD in endocrinology from the University of Calcutta in India, and has more than 14 years of experience in the pharmaceutical industry, having been associated with leading pharmaceutical companies in clinical research and project management. Of note was the successful clinical development of an antimalarial new chemical entity (NCE) (Synriam), leading to its regulatory submission and transitioning to market. Synriam became the first new drug by an Indian pharmaceutical company. Sanjukta has played significant roles in various licensing deals and alliance management for NCE codevelopment between partners. Skilled in ICH/GCP guidelines and protocols, and experienced in conducting clinical trials, Sanjukta also does medical writing involving the preparation of clinical study protocols, various relevant documents, and study reports. She also has several publications in peer-reviewed journals.


Download Report Overview

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Drugs for Treating Systemic Lupus Erythematosus: Global Markets 129 $6650
Chapter- 1: INTRODUCTION - Complimentary 2 $0
  Show Details
Chapter- 2: EXECUTIVE SUMMARY 8 $250
  Show Details
Chapter- 3: OVERVIEW 16 $1237
  Show Details
Chapter- 4: CURRENT MEDICAL PRACTICE AND MARKET PROFILES 16 $1237
  Show Details
Chapter- 5: CURRENT THERAPIES 13 $1005
  Show Details
Chapter- 6: UNMET NEEDS 5 $387
  Show Details
Chapter- 7: EMERGING THERAPIES 10 $773
  Show Details
Chapter- 8: MARKET OUTLOOK 18 $1392
  Show Details
Chapter- 9: PATENTS 17 $1315
  Show Details
Chapter- 10: COMPANY PROFILES 24 $1856
  Show Details
 
  List of Tables
  List of Figures
Recommended combos for Forecast Model
+

BCC Research Report

Price: $6650

=

Total Price: $12150

Combo Price: $9500

Discount will be applied automatically after you will add the forecast model and any report to your cart.

 
Select License type:
buy now
download report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls